• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫茎泽兰苷A3通过调节辅助性T细胞17反应改善实验性自身免疫性脑脊髓炎。

Anemoside A3 ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response.

作者信息

Ip Fanny C F, Ng Yu Pong, Or Terry C T, Sun Peiran, Fu Guangmiao, Li Jessica Y H, Ye Wen-Cai, Cheung Tom H, Ip Nancy Y

机构信息

Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.

Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.

出版信息

PLoS One. 2017 Jul 31;12(7):e0182069. doi: 10.1371/journal.pone.0182069. eCollection 2017.

DOI:10.1371/journal.pone.0182069
PMID:28759648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5536310/
Abstract

Anemoside A3 (AA3) is a natural triterpenoid glycoside isolated from the root of Pulsatilla chinensis (Bunge) Regel. We previously showed that AA3 exhibits cognitive-enhancing and neuroprotective properties. In the present study, we demonstrated that AA3 modulates inflammatory responses by regulating prostaglandin E receptor 4 signaling. Because prostaglandin E receptor 4 is involved in the pathophysiology of experimental autoimmune encephalomyelitis (EAE), an animal model of human multiple sclerosis (MS), we assessed the beneficial effect of AA3 in EAE mice. AA3 treatment significantly reduced clinical severity and inflammatory infiltrates in the spinal cord of EAE mice. In vitro studies revealed that AA3 inhibited the T cell response toward the encephalitogenic epitope of myelin oligodendrocyte glycoprotein (MOG). AA3 significantly downregulated the expressions of certain Th1 and Th17 cytokines in activated T cells re-stimulated by MOG. Moreover, AA3 inhibited the activation of STAT4 and STAT3, which are the transcription factors pivotal for Th1 and Th17 lineage differentiation, respectively, in activated T cells. Pharmacological analysis further suggested that AA3 reduced Th17 cell differentiation and expansion. In conclusion, AA3 exerts an immunomodulatory effect in EAE, demonstrating its potential as a therapeutic agent for MS in humans.

摘要

银莲花皂苷A3(AA3)是从白头翁(Pulsatilla chinensis (Bunge) Regel)根部分离得到的一种天然三萜糖苷。我们之前的研究表明,AA3具有认知增强和神经保护特性。在本研究中,我们证明AA3通过调节前列腺素E受体4信号通路来调节炎症反应。由于前列腺素E受体4参与了实验性自身免疫性脑脊髓炎(EAE)的病理生理过程,EAE是人类多发性硬化症(MS)的动物模型,因此我们评估了AA3对EAE小鼠的有益作用。AA3治疗显著降低了EAE小鼠的临床严重程度和脊髓中的炎性浸润。体外研究表明,AA3抑制T细胞对髓鞘少突胶质细胞糖蛋白(MOG)致脑炎表位的反应。AA3显著下调了由MOG重新刺激的活化T细胞中某些Th1和Th17细胞因子的表达。此外,AA3抑制了STAT4和STAT3的激活,STAT4和STAT3分别是活化T细胞中Th1和Th17谱系分化的关键转录因子。药理学分析进一步表明,AA3减少了Th17细胞的分化和扩增。总之,AA3在EAE中发挥免疫调节作用,证明了其作为人类MS治疗药物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4301/5536310/29e84dcaf665/pone.0182069.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4301/5536310/5c613d70a12b/pone.0182069.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4301/5536310/a44ce53fbd3f/pone.0182069.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4301/5536310/c6c5f20f10b3/pone.0182069.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4301/5536310/b1ba8b61d96e/pone.0182069.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4301/5536310/29e84dcaf665/pone.0182069.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4301/5536310/5c613d70a12b/pone.0182069.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4301/5536310/a44ce53fbd3f/pone.0182069.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4301/5536310/c6c5f20f10b3/pone.0182069.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4301/5536310/b1ba8b61d96e/pone.0182069.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4301/5536310/29e84dcaf665/pone.0182069.g005.jpg

相似文献

1
Anemoside A3 ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response.紫茎泽兰苷A3通过调节辅助性T细胞17反应改善实验性自身免疫性脑脊髓炎。
PLoS One. 2017 Jul 31;12(7):e0182069. doi: 10.1371/journal.pone.0182069. eCollection 2017.
2
IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.在实验性自身免疫性脑脊髓炎中,干扰素-β部分通过抑制骨桥蛋白来调节辅助性T细胞17的分化。
Mol Immunol. 2018 Jan;93:20-30. doi: 10.1016/j.molimm.2017.11.002. Epub 2017 Nov 8.
3
Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.雷帕霉素通过抑制 mTOR-STAT3 通路改善实验性自身免疫性脑脊髓炎。
Neurochem Res. 2017 Oct;42(10):2831-2840. doi: 10.1007/s11064-017-2296-7. Epub 2017 May 30.
4
An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.一种东方医学药物,兴邦培毒散通过调节T细胞反应减轻多发性硬化症实验模型中的运动麻痹。
PLoS One. 2015 Oct 7;10(10):e0138592. doi: 10.1371/journal.pone.0138592. eCollection 2015.
5
SH479, a Betulinic Acid Derivative, Ameliorates Experimental Autoimmune Encephalomyelitis by Regulating the T Helper 17/Regulatory T Cell Balance.桦木酸衍生物SH479通过调节辅助性T细胞17/调节性T细胞平衡改善实验性自身免疫性脑脊髓炎
Mol Pharmacol. 2017 May;91(5):464-474. doi: 10.1124/mol.116.107136. Epub 2017 Feb 17.
6
Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.原花青素通过 AMPK 和 PPAR-γ/ROR-γt 信号通路抑制 Th17 细胞并改善实验性自身免疫性脑脊髓炎。
Mol Neurobiol. 2016 Oct;53(8):5356-66. doi: 10.1007/s12035-015-9462-1. Epub 2015 Oct 6.
7
Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.甘露糖缀合的髓磷脂肽可激活非致病性Th1和Th17细胞,并改善实验性自身免疫性脑脊髓炎。
Exp Neurol. 2015 May;267:254-67. doi: 10.1016/j.expneurol.2014.10.019. Epub 2014 Oct 30.
8
Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.奇壬醇通过抑制Th1和Th17细胞分化及诱导效应T细胞凋亡来减轻实验性自身免疫性脑脊髓炎。
Sci Rep. 2015 Mar 12;5:9022. doi: 10.1038/srep09022.
9
A Camelid-Derived STAT-Specific Nanobody Inhibits Neuroinflammation and Ameliorates Experimental Autoimmune Encephalomyelitis (EAE).驼源 STAT 特异性纳米抗体抑制神经炎症并改善实验性自身免疫性脑脊髓炎 (EAE)。
Cells. 2024 Jun 16;13(12):1042. doi: 10.3390/cells13121042.
10
A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.一种新型人截短型IL12rβ1-Fc融合蛋白通过p40的特异性结合来抑制Th1和Th17细胞分化,从而改善实验性自身免疫性脑脊髓炎。
Oncotarget. 2015 Oct 6;6(30):28539-55. doi: 10.18632/oncotarget.5164.

引用本文的文献

1
Identification of potential immunomodulators from Pulsatilla decoction that act on therapeutic targets for ulcerative colitis based on pharmacological activity, absorbed ingredients, and in-silico molecular docking.基于药理活性、吸收成分和计算机模拟分子对接,从白头翁汤中鉴定作用于溃疡性结肠炎治疗靶点的潜在免疫调节剂。
Chin Med. 2022 Nov 24;17(1):132. doi: 10.1186/s13020-022-00684-7.
2
Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches.血管生成与多发性硬化症发病机制:新型药物治疗方法一瞥
J Clin Med. 2022 Aug 9;11(16):4643. doi: 10.3390/jcm11164643.
3
Pharmacological activities and molecular mechanisms of Pulsatilla saponins.

本文引用的文献

1
The gut microbiome and microbial translocation in multiple sclerosis.肠道微生物群与多发性硬化症中的微生物易位
Clin Immunol. 2017 Oct;183:213-224. doi: 10.1016/j.clim.2017.03.001. Epub 2017 Mar 9.
2
Diversity of immune cell types in multiple sclerosis and its animal model: Pathological and therapeutic implications.多发性硬化症及其动物模型中免疫细胞类型的多样性:病理和治疗意义。
J Neurosci Res. 2017 Oct;95(10):1973-1983. doi: 10.1002/jnr.24023. Epub 2017 Jan 13.
3
Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
白头翁皂苷的药理活性及分子机制
Chin Med. 2022 May 23;17(1):59. doi: 10.1186/s13020-022-00613-8.
4
Progress in the Application of Drugs for the Treatment of Multiple Sclerosis.用于治疗多发性硬化症的药物应用进展
Front Pharmacol. 2021 Jul 13;12:724718. doi: 10.3389/fphar.2021.724718. eCollection 2021.
5
Role of Plant-Derived Natural Compounds in Experimental Autoimmune Encephalomyelitis: A Review of the Treatment Potential and Development Strategy.植物源天然化合物在实验性自身免疫性脑脊髓炎中的作用:治疗潜力与发展策略综述
Front Pharmacol. 2021 Jun 28;12:639651. doi: 10.3389/fphar.2021.639651. eCollection 2021.
6
Kombucha ameliorates experimental autoimmune encephalomyelitis through activation of Treg and Th2 cells.康普茶通过激活 Treg 和 Th2 细胞来改善实验性自身免疫性脑脊髓炎。
Acta Neurol Belg. 2021 Dec;121(6):1685-1692. doi: 10.1007/s13760-020-01475-3. Epub 2020 Aug 18.
7
Chinese Herbal Medicine and Its Regulatory Effects on Tumor Related T Cells.中草药及其对肿瘤相关T细胞的调节作用。
Front Pharmacol. 2020 Apr 21;11:492. doi: 10.3389/fphar.2020.00492. eCollection 2020.
蛋白激酶CK2决定致脑炎性TH17细胞和调节性T细胞发育之间的分子抉择。
Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10145-50. doi: 10.1073/pnas.1523869113. Epub 2016 Aug 23.
4
Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.免疫细胞在多发性硬化症和中风中穿越中枢神经系统屏障的过程。
Biochim Biophys Acta. 2016 Mar;1862(3):461-71. doi: 10.1016/j.bbadis.2015.10.018. Epub 2015 Oct 23.
5
Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.少突胶质细胞再生:其在多发性硬化症髓鞘替代和神经保护中的意义。
Neuropharmacology. 2016 Nov;110(Pt B):633-643. doi: 10.1016/j.neuropharm.2015.10.010. Epub 2015 Oct 22.
6
Peptide immunotherapy in experimental autoimmune encephalomyelitis.实验性自身免疫性脑脊髓炎中的肽免疫疗法。
Biomed J. 2015 May-Jun;38(3):206-14. doi: 10.4103/2319-4170.158510.
7
CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes.脑脊液蛋白质组学确定了多发性硬化临床亚型的特异性和共享通路。
PLoS One. 2015 May 5;10(5):e0122045. doi: 10.1371/journal.pone.0122045. eCollection 2015.
8
Advances in the immunopathogenesis of multiple sclerosis.多发性硬化症免疫发病机制的进展
Curr Opin Neurol. 2015 Jun;28(3):206-19. doi: 10.1097/WCO.0000000000000205.
9
Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond.多发性硬化症的体内和体外实验模型:实验性自身免疫性脑脊髓炎及其他。
Mult Scler Relat Disord. 2012 Jan;1(1):15-28. doi: 10.1016/j.msard.2011.09.002. Epub 2011 Sep 16.
10
New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis.美国食品药品监督管理局(FDA)新批准的用于治疗多发性硬化症的疾病修正疗法
Clin Ther. 2015 Apr 1;37(4):691-715. doi: 10.1016/j.clinthera.2015.03.001. Epub 2015 Apr 4.